• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ARTHREX, INC. BIO-COMP SWIVELOCK C, CLD 5.5X19.1MM; BIO SOFT TISSUE FIXATN FASTNR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ARTHREX, INC. BIO-COMP SWIVELOCK C, CLD 5.5X19.1MM; BIO SOFT TISSUE FIXATN FASTNR Back to Search Results
Model Number BIO-COMP SWIVELOCK C, CLD 5.5X19.1MM
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Unspecified Infection (1930)
Date of Event 12/09/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Investigation is in process.A follow-up report will be provided upon availability of additional information.
 
Event or Problem Description
On 12/9/2024, it was reported by a facility representative via email that an ar-2323bcc biocomposite swivelock was implanted in a patient on (b)(6) 2024 during an rcr procedure.The patient developed a postoperative infection.No additional information was provided.
 
Additional Manufacturer Narrative
Additional information: b5, g3.
 
Event or Problem Description
Additional information received on 12/19/2024: on (b)(6) 2024, the patient was fourteen days postoperative and experienced a burning and throbbing pain.By (b)(6) 2024, the patient had a red and puffy incision, and the surgeon started to question if this was a superficial infection.On (b)(6) 2024, six weeks postoperative, the patient's cuff incision raised portions and had redness and purulence under the incision.The patient was referred for an incision and drainage procedure.The patient was diagnosed with a scant growth of an anaerobic diphtheroid infection.The infection was treated with clindamycin and an incision and drainage procedure on (b)(6) 2024.Additional information received on 1/7/2025: the patient's incision has healed well with a good range of motion.There are no signs or symptoms of infection.
 
Additional Manufacturer Narrative
Additional information: g3, h3, h6.Based on the information provided which may include the device (if available and returned), pictures, videos, event description, and any additional information from the field, arthrex was able to conclude a most likely cause.The most likely cause for the reported failure can be attributed to a patient-specific event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIO-COMP SWIVELOCK C, CLD 5.5X19.1MM
Common Device Name
BIO SOFT TISSUE FIXATN FASTNR
Manufacturer (Section D)
ARTHREX, INC.
1370 creekside boulevard
naples FL 34108 1945
Manufacturer (Section G)
ARTHREX, INC.
1370 creekside boulevard
naples FL 34108 1945
Manufacturer Contact
jared engle
8009337001
MDR Report Key21079707
Report Number1220246-2025-09219
Device Sequence Number8333746
Product Code MAI
UDI-Device Identifier00888867026728
UDI-Public(01)00888867026728(11)240509(17)280430(10)15246170
Combination Product (Y/N)N
Initial Reporter StateWI
Initial Reporter CountryUS
PMA/510(K) Number
K203495
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Reporter Type Manufacturer
Report Source User Facility
Initial Reporter Occupation Administrator/Supervisor
Type of Report Initial,Followup,Followup
Report Date (Section B) 07/10/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberBIO-COMP SWIVELOCK C, CLD 5.5X19.1MM
Device Catalogue NumberAR-2323BCC
Device Lot Number15246170
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/09/2024
Supplement Date Received by Manufacturer12/19/2024
06/13/2025
Initial Report FDA Received Date01/06/2025
Supplement Report FDA Received Date01/15/2025
07/10/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured05/09/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-